Caplyta 21 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F67F4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,387
Award facts
- Contract value 100% obligated
- $15,387.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,387.13 delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of CAPLYTA 21 mg capsules (30-count units). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 2, 2026, and will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. Amerisourcebergen operates as a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order represents a task order issued under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs. CAPLYTA is an atypical antipsychotic medication used in the treatment of schizophrenia and bipolar disorder, reflecting the broad range of neurological and psychiatric treatments that Amerisourcebergen delivers through its federal contract portfolio to the Defense Health Agency and other military medical facilities.
Quick answers
Who was awarded contract SPE2DR26F67F4?
SPE2DR26F67F4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F67F4 worth?
The government has obligated $15,387 on SPE2DR26F67F4.
Is contract SPE2DR26F67F4 an order under another contract?
Yes. SPE2DR26F67F4 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F67F4 competed?
The extent of competition for SPE2DR26F67F4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award